1-2 of 2
Authors: Isabelle Hardy
Journal Article
P-576. Real-world Experience with the Two-Drug Regimen Dolutegravir/Lamivudine for the Treatment of HIV-1 among Vulnerable People Living with HIV in Canada: Preliminary Results from a Chart Review Study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.774, https://doi.org/10.1093/ofid/ofae631.774
Published: 29 January 2025
Journal Article
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data
Open Forum Infectious Diseases, Volume 7, Issue 11, November 2020, ofaa404, https://doi.org/10.1093/ofid/ofaa404
Published: 04 September 2020
